Header Logo

Connection

MICHAEL R MIGDEN to Protein Kinase Inhibitors

Back to Details
This is a "connection" page, showing publications MICHAEL R MIGDEN has written about Protein Kinase Inhibitors.
MICHAEL R MIGDEN
Connection Strength
0.056
Protein Kinase Inhibitors
  1. Disseminated anaplastic pleomorphic xanthoastrocytoma with posttreatment fat necrosis during combined BRAF and MEK inhibitors therapy. Pediatr Blood Cancer. 2019 12; 66(12):e27974.
    View in: PubMed
    Score: 0.056
Connection Strength

The connection strength for concepts is the sum of the scores for each matching publication.

Publication scores are based on many factors, including how long ago they were written and whether the person is a first or senior author.